GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)Stock · Health Care$52.17+$0.71 (+1.38%)as of market close, Aug 6, 2026
GSK — GSK plc American Depositary Shares (Each representing two Ordinary Shares) stock price, chart and key statistics
Key stats
Price data
- Price
- $52.17
- Change YTD
- +6.38%
- Market cap
- 214.8B
- Enterprise value
- 234.1B
- Shares outstanding
- 4.1B
- 52W low
- $36.75
- 52W high
- $61.70
- From 52W high
- -15.45%
- From 52W low
- +41.96%
- 52W range
- 62%
- Beta
- 0.38
Volume
- Rel volume
- 0.52×
- 30D volume
- 4.3M
- 30D $ vol
- 223.6M
Fundamentals
- Sales (ttm)
- 43.1B
- Sales/share
- $10.48
- EPS (ttm)
- $1.83
- FCF (ttm)
- 10.2B
- FCF/share
- $2.48
- Book value/share
- $5.36
- Net margin
- 19.25%
- ROE
- 37.65%
- ROA
- 10.09%
- Debt / equity
- 0.90×
- Current ratio
- 0.82
Growth (CAGR, ttm) · 10Y
- Sales
- +1.66%
- Net income
- -4.24%
- Shares
- -1.70%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -3.56%
- Sales/share
- +3.42%
- Book value/share
- +7.12%
- Dividend/share
- -3.33%
- Price
- +1.51%
- Total return
- +6.33%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 28.5×
- P/OI (ttm)
- 20.5×
- Fwd P/E
- 10.0×
- P/S (ttm)
- 5.0×
- P/B (mrq)
- 9.7×
- P/FCF (ttm)
- 21.0×
- EV/EBITDA (fy)
- 17.3×
- EV/Sales (ttm)
- 5.4×
- FCF yield (ttm)
- 4.76%
- Dividend yield (fwd)
- 1.67%
- Dividend/share (fwd)
- $0.87
- Buyback yield (realized, 1y)
- 0.60%
- Shareholder yield (realized, 1y)
- 2.18%
- Buyback yield (cash, ttm)
- 0.84%
- Shareholder yield (cash, ttm)
- 2.41%
Vs own 10Y history
- P/E
- 42nd
- P/OI
- 30th
- P/S
- 61st
- P/B
- 38th
Bar = where today's multiple sits in GSK's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return
1D
+1.38%
1W
+0.19%
1M
-0.67%
3M
+3.25%
YTD
+6.38%
1Y
+39.79%
5Y
+30.10%
Financial statements
Open full GSK financials →Related Health Care
1MGSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) trades at $52.17 with a live price and an interactive chart covering 46+ years of daily price history, plus key valuation metrics. ChartRow also publishes GSK's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GSK financial statements →